Clinical Trial Update: Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 18F-FET PET imaging for pituitary adenomas with indeterminate MRI findings; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Pituitary Adenoma

Drugs mentioned

• 18F-FET PET tracer (18F-fluoroethyl-tyrosine)

Snippet

Sponsor: University Hospital, Lille | Conditions: Functional Pituitary Adenomas | Phase 2 | Status: NOT_YET_RECRUITING